22OCT

NPIF II hits £275m across 449 Northern deals

3 min read

16:30UTC

The British Business Bank marked two years of the Northern Powerhouse Investment Fund II on 12 May with £275m deployed to 400-plus businesses across 449 deals at a 44% private leverage ratio.

← Back to Stryker agrees option to buy CMR Surgical Jump to analysis ↓

TechnologyDeveloping

Key takeaway

NPIF II hits the £25k-£2m band that the BBB direct mandate cannot reach.

The British Business Bank (BBB) marked the second anniversary of the Northern Powerhouse Investment Fund II (NPIF II) on 12 May with £275m committed to more than 400 businesses across 449 completed deals⁠¹. Of that, £151.3m was direct BBB capital and £122.6m came from private co-investors, a 44% private-leverage ratio. The fund's total size is £660m, deploying loans of £25,000 to £2m and equity tickets up to £5m across Greater Manchester, Lancashire, Merseyside, Cheshire, Cumbria, Yorkshire, Tees Valley, Durham, Northumberland, Tyneside and Sunderland.

NPIF II is delivered through PXN Ventures, FW Capital, River Capital and GC Business Finance rather than the bank's own balance sheet. That structural choice matters when read against the BBB's expanded £6.6bn direct mandate, which has produced £40m into Quantum Motion, £12m into Cytospire and £13m into Elliptic at the Series A and above tier. NPIF II reaches the band those direct cheques do not: micro-loans, regional seed equity, the £25k-to-£2m range that VCT-backed angel networks historically served before the income tax relief was cut from 30% to 20%.

The regional spread also shifts the spatial map. London takes the Headline funding numbers in every quarterly Beauhurst tally, but the NPIF II ledger now contains 449 deals concentrated in the North across two years, with the 44% co-investment ratio showing that private regional VC is following BBB capital rather than waiting for it. The structural question for the BBB's next two years is whether the bank's direct mandate can replicate that leverage ratio on its single-name £40m cheques.

Deep Analysis

In plain English

The Northern Powerhouse Investment Fund II is a £660m pot of money specifically for businesses in the North of England, managed by the British Business Bank. Two years in, it has given out £275m across 449 different businesses, with loans starting as small as £25,000. It also attracted an additional £122.6m from private investors who joined alongside the public money. This matters because the North of England has historically struggled to attract investment compared to London and the South. The fund is deliberately targeting businesses that are too small or too early-stage for the big institutional investors making headlines in London, filling a gap that would otherwise leave thousands of Northern entrepreneurs unable to grow.

Deep Analysis

Root Causes

NPIF II's 0.81x private leverage ratio reflects two structural conditions in Northern England's capital market.

First, the venture capital fund management ecosystem in the North is thin compared to London. Most NPIF II fund managers are regional vehicles that rely on NPIF capital to maintain their own operations; they are not independently capitalisable businesses that could raise private successor funds. This creates a dependency loop: NPIF II catalyses deal flow but does not build the fund management infrastructure that would survive its termination.

Second, Northern England's SME base is more concentrated in manufacturing, logistics, property and professional services than in the digital and tech sectors where private co-investment is deepest. A £100k loan to a Leeds manufacturer does not attract a Balderton co-investor the way a £100k pre-seed to a Manchester AI startup might.

What could happen next?

Risk
NPIF II is 42% deployed at two years on a fund with no published successor announcement; if the remaining £385m deploys on the same trajectory, the fund exhausts in 2028 and Northern businesses face a capital cliff unless a third iteration is committed.
Opportunity
449 NPIF II businesses two years in represent a pipeline for BBB's direct-mandate investments at Series A and beyond; the fund's deal data is the UK's richest source of early-stage performance data for Northern deeptech.

Source Landscape

This story draws on neutral-leaning sources from United Kingdom

United Kingdom×2

LeftRight

Primary parallel: The Regional Development Agencies' venture finance programmes (1998-2012) deployed a similar mix of direct loans and equity across the North, Midlands and South West. All were wound up in 2012 following the LEP transition; the private markets they were meant to catalyse mostly did not persist.

NPIF I (the predecessor to NPIF II) partially addressed this by using fund managers rather than direct agency deployment, which created more commercially-oriented deal selection. NPIF II continues the fund-manager model; the question is whether the fund managers are building the relationships that survive beyond the public capital mandate.

Counter-parallel: Invest NI's Access to Finance suite in Northern Ireland has maintained continuous regional fund deployment since 2014 with a stable private co-investment ratio above 1.0x in its equity component; the consistency reflects a smaller, more concentrated business community where fund managers can build relationship depth. NPIF II's Northern England mandate covers a more dispersed geography, which structurally limits relationship density.

Consensus view: Northern Powerhouse Partnership's Henri Murison and Sheffield Hallam University's Steve Fothergill both assess NPIF II's 44% private leverage ratio as the key metric: £122.6m in private co-investment alongside £151.3m of public capital over two years is a leverage multiple of 0.81x, below the 1.0x target typically cited for regional fund programmes.

The leverage gap suggests the North's private co-investment ecosystem is still not deep enough to match public capital on a deal-by-deal basis, which is the structural problem NPIF II was designed to address.

Counter-view: IPPR North's Sarah Longlands argues the leverage metric is the wrong measure for a regional fund at its stage. NPIF II is filling a vacuum, not catalysing a pre-existing market; the 449 deals completed in two years represent businesses that had no viable alternative, and measuring leverage against a hypothetical private market baseline assumes a counterfactual that does not exist in most Northern business corridors.

Key tension: Whether NPIF II's primary purpose is to demonstrate regional co-investment market viability (leverage metric), or to ensure businesses in the North get capital they cannot access elsewhere (deployment metric), because the two criteria produce different evaluations of the programme's success.

Sources:MassDevice·Fierce Biotech·Tech.eu

Mentions:Northern Powerhouse Investment Fund II →British Business Bank →Quantum Motion →Northern Ireland →Elliptic →Ireland →England →Lancashire →Cumbria →Beauhurst →Sunderland →Manchester Airport →Greater Manchester →Merseyside →

First Reported In

Update #5 · State capital splits, allied money fills gap

MassDevice· 21 May 2026

Read original →

Causes and effects

This Event

NPIF II hits £275m across 449 Northern deals

The BBB's regional fund reaches the ticket band the bank's headline direct cheques do not touch.

Led to

Seedcamp closes its record $320m fund

BBB's £275m NPIF II deployment across 449 Northern businesses is part of the same multi-tier strategy in which the Seedcamp LP stake sits.

Occurred 22 Jun 2026

Read story →

Different Perspectives

Abu Dhabi Investment Council

The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

CDP Venture Capital

CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.

EDBI

Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.

Forbion

Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.

British Business Bank

The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.

Stryker Corporation

Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.